Systematic review of chorioamnionitis and cerebral palsy

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 8, Issue 1, 2002, Pages 25-29

  Wu, Yvonne W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cerebral palsy; Chorioamnionitis; Cystic periventricular leukomalacia; Meta analysis

Indexed keywords

CEREBRAL PALSY; CHORIOAMNIONITIS; DISEASE ASSOCIATION; ENCEPHALOMALACIA; GESTATIONAL AGE; HUMAN; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

CEREBRAL PALSY; CHORIOAMNIONITIS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PREGNANCY; RISK FACTORS;

EID: 0036316921     PISSN: 10804013     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrdd.10003     Document Type: Review

References (48)

1. Infectious diseases in pregnancy, cytokines and neurological impairment: An hypothesis
2. Antecedents of cerebral palsy in a multicenter trial of indomethacin for intraventricular hemorrhage
3. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants
4. Ultrasonically established cystic periventricular leukomalacia (PVL): Incidence and associated factors in Switzerland 1995-1997
5. The epidemiology of placental features: Associations with gestational age and neonatal outcome
6. Impact of improved survival of very low birth weight infants on recent secular trends in the prevalence of cerebral palsy
7. Intrapartum asphyxia: A rare cause of cerebral palsy
8. Cerebral palsy in very low birthweight infants
9. Cerebral palsy in four northern California counties, births 1983 through 1985
10. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn
11. Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant
12. Factor V Leiden may predispose fetuses to cerebral palsy
13. The etiology of cerebral palsy
14. Survival and neonatal and neurodevelopmental outcome of 24-29 week gestation infants according to primary cause of preterm delivery
15. Casecontrol study of maternal antenatal rsik-factors for cerebral palsy in extremely preterm infants
16. Maternal infection and cerebral palsy in infants of normal birth weight
17. Intrauterine infection and cerebral palsy in preterm children
18. Prenatal and perinatal factors and cerebral palsy in very low birth weight infants
19. Risk factors for fever in labor
20. A case-control study of chorioanmionic infection and histologic chorioamnionitis in prematurity
21. Cerebral palsy in preterm infants: A population based analysis of antenatal risk factors
22. Prospective evaluation of perinatal risk factors for cerebral palsy and delayed development in high risk infants
23. Cerebral palsy
24. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants
25. Statistical aspects of the analysis of data from retrospective studies of disease
26. Intrauterine infection, magnesium sulfate exposure and cerebral palsy in infants born between 26 and 30 weeks of gestation
27. Case-control study of antenatal and intraparturn risk factors for cerebral palsy in very preterm singleton babies
28. Antecedents of cerebral palsy. I. Univariate analysis of risks
29. Predictors of low and very low birth weight and the relation of these to cerebral palsy
30. Neonatal cytokines and coagulation factors in children with cerebral palsy
31. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?
32. Potentially asphyxiating conditions and spastic cerebral palsy in infants of normal birth weight
33. The association of clinical and histologic chorioamnionitis (CA) with cystic periventricular leukomalacia (cPVL) and cerebral palsy (CP) in preterm infants
34. Intrauterine infection and the risk of cerebral palsy in very low-birthweight infants
35. Intrapartum hypoxic-ischemic cerebral injury and subsequent cerebral palsy: Medicolegal issues
36. Bilateral cystic periventricular leukomalacia in the premature infant: Associated risk factors
37. Urinary tract infection during pregnancy: A risk factor for cerebral palsy?
38. Placental lesions associated with neurologic impairment and cerebral palsy in very low-birth-weight infants
39. Placental abnormalities: Insights into pathogenesis of cystic periventricular leukomalacia
40. Obstetric risk factors for periventricular leukomalacia among preterm infants
41. Brain injury in the premature infant - From pathogenesis to prevention
42. Perinatal correlates of cerebral palsy and other neurologic impairment among very low birth weight children
43. Effects of hypocarbia on the development of cystic periventricular leukomalacia in premature infants treated with high-frequency jet ventilation
44. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis
45. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy
46. Fetal exposure to an intra-anmiotic inflammation and the development of cerebral palsy at the age of three years
47. Periventricular leukomalacia: Risk factors revisited